Hanmi Pharm Co Ltd
KRX:128940
Hanmi Pharm Co Ltd
KRX:128940
Price:
266 000
KRW
-0.19%
Market Cap:
3.4T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Hanmi Pharm Co Ltd
266000
-500 (-0.19%)
| 52 Week Range |
245 000
366 169.2238
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Hanmi Pharm Co Ltd
Income Statement
Earnings Waterfall
Hanmi Pharm Co Ltd
Hanmi Pharm Co Ltd
|
Revenue
|
1.6T
KRW
|
|
Cost of Revenue
|
-691.3B
KRW
|
|
Gross Profit
|
874.9B
KRW
|
|
Operating Expenses
|
-619.1B
KRW
|
|
Operating Income
|
255.8B
KRW
|
|
Other Expenses
|
-95.2B
KRW
|
|
Net Income
|
160.7B
KRW
|
Income Statement
Hanmi Pharm Co Ltd
Hanmi Pharm Co Ltd
Currency: KRW
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
743 779
N/A
|
761 280
+2%
|
791 905
+4%
|
850 027
+7%
|
939 070
+10%
|
1 317 535
+40%
|
1 359 164
+3%
|
1 349 235
-1%
|
1 300 580
-4%
|
882 725
-32%
|
859 901
-3%
|
848 177
-1%
|
856 033
+1%
|
916 586
+7%
|
928 713
+1%
|
947 203
+2%
|
954 879
+1%
|
1 015 962
+6%
|
1 044 929
+3%
|
1 074 014
+3%
|
1 104 465
+3%
|
1 113 650
+1%
|
1 127 207
+1%
|
1 100 224
-2%
|
1 101 450
+0%
|
1 075 854
-2%
|
1 057 968
-2%
|
1 093 864
+3%
|
1 130 014
+3%
|
1 203 186
+6%
|
1 253 997
+4%
|
1 291 788
+3%
|
1 330 854
+3%
|
1 331 547
+0%
|
1 371 607
+3%
|
1 397 244
+2%
|
1 419 708
+2%
|
1 490 887
+5%
|
1 533 383
+3%
|
1 568 781
+2%
|
1 566 245
0%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(328 677)
|
(338 777)
|
(357 165)
|
(369 883)
|
(383 385)
|
(398 251)
|
(412 633)
|
(423 220)
|
(423 276)
|
(421 869)
|
(408 454)
|
(397 466)
|
(393 188)
|
(398 182)
|
(402 832)
|
(413 460)
|
(428 545)
|
(475 047)
|
(483 473)
|
(501 314)
|
(505 441)
|
(481 168)
|
(492 940)
|
(480 841)
|
(509 758)
|
(494 935)
|
(494 992)
|
(519 236)
|
(521 429)
|
(570 433)
|
(594 763)
|
(607 998)
|
(618 877)
|
(612 994)
|
(618 729)
|
(630 144)
|
(642 307)
|
(661 638)
|
(684 711)
|
(693 611)
|
(691 296)
|
|
| Gross Profit |
415 101
N/A
|
422 503
+2%
|
434 740
+3%
|
480 144
+10%
|
555 684
+16%
|
919 284
+65%
|
946 530
+3%
|
926 014
-2%
|
877 304
-5%
|
460 856
-47%
|
451 447
-2%
|
450 711
0%
|
462 844
+3%
|
518 404
+12%
|
525 880
+1%
|
533 742
+1%
|
526 334
-1%
|
540 916
+3%
|
561 456
+4%
|
572 700
+2%
|
599 024
+5%
|
632 482
+6%
|
634 267
+0%
|
619 383
-2%
|
591 692
-4%
|
580 918
-2%
|
562 977
-3%
|
574 629
+2%
|
608 586
+6%
|
632 752
+4%
|
659 234
+4%
|
683 790
+4%
|
711 978
+4%
|
718 553
+1%
|
752 878
+5%
|
767 100
+2%
|
777 401
+1%
|
829 249
+7%
|
848 673
+2%
|
875 170
+3%
|
874 949
0%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(370 255)
|
(388 051)
|
(418 995)
|
(470 382)
|
(508 978)
|
(707 484)
|
(727 683)
|
(703 218)
|
(676 457)
|
(434 084)
|
(461 635)
|
(445 750)
|
(398 049)
|
(436 241)
|
(448 836)
|
(458 295)
|
(465 697)
|
(457 341)
|
(483 691)
|
(486 277)
|
(509 158)
|
(528 604)
|
(531 248)
|
(528 655)
|
(554 738)
|
(531 943)
|
(512 324)
|
(519 190)
|
(483 982)
|
(507 336)
|
(522 908)
|
(531 745)
|
(550 010)
|
(560 463)
|
(575 729)
|
(588 376)
|
(587 964)
|
(608 558)
|
(611 255)
|
(612 798)
|
(619 119)
|
|
| Selling, General & Administrative |
(246 971)
|
(249 516)
|
(261 608)
|
(301 012)
|
(338 675)
|
(515 720)
|
(527 645)
|
(510 319)
|
(485 435)
|
(287 917)
|
(270 048)
|
(257 514)
|
(252 517)
|
(284 952)
|
(291 251)
|
(291 492)
|
(294 419)
|
(291 436)
|
(298 362)
|
(311 595)
|
(323 145)
|
(334 316)
|
(338 190)
|
(329 201)
|
(325 321)
|
(319 555)
|
(319 870)
|
(334 838)
|
(343 349)
|
(361 309)
|
(377 286)
|
(389 816)
|
(404 966)
|
(406 146)
|
(411 239)
|
(414 673)
|
(415 028)
|
(426 789)
|
(429 643)
|
(426 802)
|
(425 835)
|
|
| Research & Development |
(119 832)
|
(135 168)
|
(151 272)
|
(163 529)
|
(167 012)
|
(167 987)
|
(162 806)
|
(155 392)
|
(153 498)
|
(141 952)
|
(142 438)
|
(139 067)
|
(142 896)
|
(151 289)
|
(156 724)
|
(166 803)
|
(162 807)
|
(165 906)
|
(179 834)
|
(174 682)
|
(186 013)
|
(194 288)
|
(189 392)
|
(196 005)
|
(229 419)
|
(212 387)
|
(192 925)
|
(184 352)
|
(140 632)
|
(146 027)
|
(145 622)
|
(141 929)
|
(145 044)
|
(154 317)
|
(164 490)
|
(173 702)
|
(172 935)
|
(181 769)
|
(181 612)
|
(185 996)
|
(193 284)
|
|
| Depreciation & Amortization |
(3 450)
|
(3 367)
|
(3 242)
|
(2 985)
|
(2 894)
|
(23 776)
|
(23 826)
|
(24 100)
|
(24 119)
|
(4 214)
|
(3 386)
|
(3 406)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
(2 873)
|
(2 856)
|
(397)
|
0
|
(13 406)
|
(13 407)
|
(13 405)
|
0
|
(45 763)
|
(45 763)
|
(2 636)
|
0
|
(861)
|
0
|
(8 471)
|
0
|
(5 495)
|
0
|
0
|
0
|
(3 666)
|
(3 449)
|
0
|
0
|
471
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
44 847
N/A
|
34 452
-23%
|
15 744
-54%
|
9 762
-38%
|
46 706
+378%
|
211 800
+353%
|
218 848
+3%
|
222 796
+2%
|
200 846
-10%
|
26 772
-87%
|
(10 189)
N/A
|
4 960
N/A
|
64 796
+1 206%
|
82 164
+27%
|
77 045
-6%
|
75 448
-2%
|
60 636
-20%
|
83 574
+38%
|
77 764
-7%
|
86 422
+11%
|
89 866
+4%
|
103 878
+16%
|
103 020
-1%
|
90 729
-12%
|
36 955
-59%
|
48 976
+33%
|
50 653
+3%
|
55 439
+9%
|
124 604
+125%
|
125 416
+1%
|
136 327
+9%
|
152 045
+12%
|
161 968
+7%
|
158 090
-2%
|
177 149
+12%
|
178 724
+1%
|
189 437
+6%
|
220 691
+16%
|
237 418
+8%
|
262 372
+11%
|
255 830
-2%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(8 928)
|
310
|
12 913
|
14 730
|
16 596
|
6 682
|
8 426
|
23 181
|
8 563
|
24 077
|
10 598
|
(13 697)
|
(6 181)
|
(16 477)
|
(20 251)
|
(5 413)
|
(8 554)
|
(18 442)
|
(17 312)
|
(26 451)
|
(30 535)
|
(13 317)
|
(34 657)
|
(26 820)
|
(21 516)
|
(23 531)
|
(12 853)
|
(20 127)
|
(14 946)
|
(8 619)
|
(10 376)
|
(11 211)
|
(14 288)
|
(25 795)
|
(25 677)
|
(25 997)
|
(23 922)
|
(21 395)
|
(19 051)
|
(15 357)
|
(17 951)
|
|
| Non-Reccuring Items |
(4 899)
|
(2 873)
|
0
|
0
|
0
|
(13 406)
|
0
|
0
|
0
|
(45 764)
|
0
|
0
|
(46 467)
|
(4 551)
|
(7 694)
|
(9 174)
|
0
|
(8 639)
|
0
|
(4 231)
|
(4 321)
|
(3 666)
|
0
|
0
|
(3 368)
|
471
|
0
|
472
|
479
|
(953)
|
(1 274)
|
(1 405)
|
(3 575)
|
(4 747)
|
(4 702)
|
(4 847)
|
(637)
|
(5 990)
|
(5 717)
|
(5 496)
|
(7 557)
|
|
| Gain/Loss on Disposition of Assets |
(317)
|
(201)
|
(207)
|
15
|
29
|
(7)
|
(1)
|
(56)
|
(136)
|
(1)
|
(117)
|
(148)
|
1 698
|
1 820
|
1 790
|
1 698
|
(133)
|
(1 359)
|
(1 436)
|
(1 357)
|
(2 022)
|
(3 678)
|
(3 611)
|
(3 516)
|
(3 171)
|
(718)
|
(731)
|
(1 781)
|
(1 503)
|
(1 062)
|
(1 030)
|
355
|
405
|
452
|
440
|
31
|
1 790
|
1 769
|
1 775
|
1 816
|
46
|
|
| Total Other Income |
3 410
|
4 773
|
5 946
|
5 761
|
922
|
4 515
|
2 621
|
3 458
|
7 082
|
2 914
|
2 009
|
(918)
|
(3 115)
|
(4 105)
|
(3 652)
|
(1 675)
|
(939)
|
(4 779)
|
(4 722)
|
8 022
|
8 257
|
53
|
12 122
|
(2 724)
|
(3 052)
|
(3 067)
|
(2 806)
|
(1 387)
|
(2 277)
|
(11 085)
|
(10 773)
|
(11 074)
|
(10 024)
|
(6 987)
|
(7 303)
|
(8 574)
|
(8 945)
|
(1 109)
|
(789)
|
(1 193)
|
(4 316)
|
|
| Pre-Tax Income |
34 114
N/A
|
36 461
+7%
|
34 397
-6%
|
30 268
-12%
|
64 253
+112%
|
209 585
+226%
|
229 892
+10%
|
249 378
+8%
|
216 355
-13%
|
7 998
-96%
|
2 303
-71%
|
(9 801)
N/A
|
10 732
N/A
|
58 850
+448%
|
47 238
-20%
|
60 885
+29%
|
51 011
-16%
|
50 355
-1%
|
54 294
+8%
|
62 404
+15%
|
61 244
-2%
|
83 270
+36%
|
76 873
-8%
|
57 668
-25%
|
5 847
-90%
|
22 130
+278%
|
34 262
+55%
|
32 615
-5%
|
106 357
+226%
|
103 697
-3%
|
112 875
+9%
|
128 709
+14%
|
134 486
+4%
|
121 013
-10%
|
139 906
+16%
|
139 337
0%
|
157 724
+13%
|
193 967
+23%
|
213 635
+10%
|
242 143
+13%
|
226 053
-7%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
5 395
|
6 834
|
8 501
|
16 631
|
(45 592)
|
(47 524)
|
(43 068)
|
(53 783)
|
10 569
|
22 302
|
11 667
|
14 485
|
10 465
|
10 124
|
8 330
|
(2 998)
|
(2 494)
|
(16 199)
|
(14 064)
|
(16 131)
|
(19 525)
|
(19 402)
|
(18 793)
|
(14 237)
|
(2 518)
|
(4 841)
|
(5 272)
|
(1 136)
|
(15 575)
|
(22 218)
|
(29 575)
|
(31 014)
|
(33 608)
|
(19 454)
|
(13 724)
|
(17 068)
|
(6 200)
|
(28 601)
|
(34 746)
|
(34 946)
|
(44 434)
|
|
| Income from Continuing Operations |
39 508
|
43 295
|
42 898
|
46 899
|
18 661
|
162 060
|
186 825
|
195 596
|
226 925
|
30 300
|
13 970
|
4 684
|
21 198
|
68 974
|
55 569
|
57 888
|
48 517
|
34 156
|
40 230
|
46 273
|
41 719
|
63 867
|
58 081
|
43 433
|
3 331
|
17 290
|
28 991
|
31 479
|
90 782
|
81 478
|
83 299
|
97 695
|
100 878
|
101 558
|
126 183
|
122 269
|
151 524
|
165 366
|
178 888
|
207 197
|
181 619
|
|
| Income to Minority Interest |
(7 206)
|
(7 786)
|
(9 139)
|
(9 312)
|
(8 911)
|
(7 617)
|
(6 966)
|
(6 913)
|
(6 732)
|
(6 974)
|
(9 792)
|
(8 116)
|
(8 782)
|
(8 539)
|
(6 398)
|
(7 767)
|
(7 513)
|
(9 265)
|
(10 258)
|
(11 380)
|
(11 903)
|
(11 758)
|
(11 172)
|
(7 382)
|
(4 568)
|
(5 330)
|
(5 528)
|
(8 387)
|
(13 444)
|
(14 453)
|
(15 803)
|
(18 888)
|
(20 098)
|
(18 766)
|
(19 758)
|
(20 288)
|
(20 208)
|
(19 135)
|
(20 803)
|
(22 821)
|
(20 954)
|
|
| Net Income (Common) |
32 303
N/A
|
35 510
+10%
|
33 761
-5%
|
37 588
+11%
|
9 751
-74%
|
154 443
+1 484%
|
179 859
+16%
|
188 683
+5%
|
220 193
+17%
|
23 326
-89%
|
4 178
-82%
|
(3 432)
N/A
|
12 416
N/A
|
60 434
+387%
|
49 171
-19%
|
50 121
+2%
|
41 004
-18%
|
24 891
-39%
|
29 972
+20%
|
34 892
+16%
|
29 815
-15%
|
52 110
+75%
|
46 907
-10%
|
36 049
-23%
|
(1 238)
N/A
|
11 959
N/A
|
23 463
+96%
|
23 093
-2%
|
77 338
+235%
|
67 025
-13%
|
67 497
+1%
|
78 807
+17%
|
80 780
+3%
|
82 792
+2%
|
106 424
+29%
|
101 982
-4%
|
131 316
+29%
|
146 231
+11%
|
158 086
+8%
|
184 377
+17%
|
160 664
-13%
|
|
| EPS (Diluted) |
2 691.91
N/A
|
3 228.18
+20%
|
2 813.41
-13%
|
3 132.33
+11%
|
812.58
-74%
|
12 870.25
+1 484%
|
14 988.25
+16%
|
15 723.58
+5%
|
18 349.41
+17%
|
1 943.83
-89%
|
348.16
-82%
|
-286
N/A
|
1 034.66
N/A
|
5 036.16
+387%
|
4 097.58
-19%
|
4 176.75
+2%
|
3 417
-18%
|
2 074.25
-39%
|
2 497.66
+20%
|
2 907.66
+16%
|
2 484.58
-15%
|
4 342.5
+75%
|
3 908.91
-10%
|
3 004.08
-23%
|
-103.16
N/A
|
996.58
N/A
|
1 955.25
+96%
|
1 889.12
-3%
|
6 202.57
+228%
|
5 269.72
-15%
|
5 418.18
+3%
|
6 328.06
+17%
|
6 486.48
+3%
|
6 517.19
+0%
|
8 383.89
+29%
|
8 036.04
-4%
|
10 347.58
+29%
|
11 522.12
+11%
|
12 464.77
+8%
|
14 540.49
+17%
|
12 670.49
-13%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
